Inventor

OLENIK BRITTA

DE26 patents

⚠️ This page may combine multiple inventors who share the name “OLENIK BRITTA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OLENIK BRITTA

Bayer Pharma AG

Orally administrable modified-release pharmaceutical dosage form

Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient

Orally administrable modified-release pharmaceutical dosage form

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Salts

Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof

BAYER CROPSCIENCE AG

Crystal forms of the monosodium salt of foramsulfuron

Process for preparing tetrazole-substituted anthranilamide derivatives and novel crystal polymorphs of these derivatives

Crystal forms of the monosodium salt of foramsulfuron

Solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one

Crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1, 3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulphonate

Crystal modification II of 2-[2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxy-propyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione

Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide

BAYER AG

Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4&#39;-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound

Treatment of cardiopulmonary disorders

Process for preparing a tetrazole-substituted anthranilic acid diamide derivative

OLENIK BRITTA

Solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one

Crystalline modification of 4-(N-methyl-Z-chloro-5pyridy methylamino)-2, 5-dihydrofuran-2-on

Thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]phenyl} carbonyl)cyclohexane-1,3-dione

PH PHARMA CO LTD

Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile

Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile

ANGERMANN ALFRED

Herbicidal composition comprising the hydrates of saflufenacil and glyphosate or glufosinate

VIRBAC

Tablet comprising modoflaner as an active component

PAZENOK SERGII

Process for preparing tetrazole-substituted anthranilamide derivatives and novel crystal polymorphs of these derivatives

VETOQUINOL SA

Method for preparing 2-chloro-n-(1-cyanocyclopropyl)-5-[2′-methyl-5′-(pentafluoroethyl)-4′-(trifluoromethyl)-2′h-1,3′-bipyrazol-4-yl]benzamide

Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound